High‐molecular‐weight kininogen binds two molecules of cysteine proteinases with different rate constants

[1]  C. Pace,et al.  How to measure and predict the molar absorption coefficient of a protein , 1995, Protein science : a publication of the Protein Society.

[2]  C. Boudier,et al.  High‐affinity binding of two molecules of cysteine proteinases to low‐molecular‐weight kininogen , 1995, Protein science : a publication of the Protein Society.

[3]  B. Lenarčič,et al.  Inhibition of cruzipain, the major cysteine proteinase of the protozoan parasite, Trypanosoma cruzi, by proteinase inhibitors of the cystatin superfamily , 1995, FEBS letters.

[4]  N. Martin,et al.  Interaction of cysteine proteinases with recombinant kininogen domain 2, expressed in Escherichia coli , 1995, FEBS letters.

[5]  R. Colman,et al.  High molecular weight kininogen binds to Mac-1 on neutrophils by its heavy chain (domain 3) and its light chain (domain 5). , 1994, The Journal of biological chemistry.

[6]  V. Turk,et al.  Kinetics of inhibition of bovine cathepsin S by bovine stefin B , 1994, FEBS letters.

[7]  S. Olson,et al.  High molecular weight kininogen potentiates the heparin-accelerated inhibition of plasma kallikrein by antithrombin: role for antithrombin in the regulation of kallikrein. , 1993, Biochemistry.

[8]  E. Auerswald,et al.  Cloning, expression and characterization of human kininogen domain 3 , 1993, FEBS letters.

[9]  V. Turk,et al.  Bovine stefin C, a new member of the stefin family. , 1993, Journal of Biological Chemistry.

[10]  S. Olson,et al.  Role of the antithrombin-binding pentasaccharide in heparin acceleration of antithrombin-proteinase reactions. Resolution of the antithrombin conformational change contribution to heparin rate enhancement. , 1992, The Journal of biological chemistry.

[11]  M. Pagano.  Comparison of cysteine-proteinases inhibitory properties of human high-molecular-weight-kininogen (HMrK) purified from plasma and serum. , 1992, Thrombosis research.

[12]  A. Schmaier,et al.  Low molecular weight kininogen binds to platelets to modulate thrombin-induced platelet activation. , 1991, The Journal of biological chemistry.

[13]  H. Halvorson,et al.  Quantitative characterization of the thrombin-heparin interaction. Discrimination between specific and nonspecific binding models. , 1991, The Journal of biological chemistry.

[14]  R. Colman,et al.  Structure and functions of human kininogens. , 1991, Trends in pharmacological sciences.

[15]  I. Björk,et al.  Kinetics of binding of chicken cystatin to papain. , 1989, Biochemistry.

[16]  S. Olson,et al.  Binding of heparin to human high molecular weight kininogen. , 1989, Biochemistry.

[17]  I. Assfalg-Machleidt,et al.  Proteinase-sensitive regions in the heavy chain of low molecular weight kininogen map to the inter-domain junctions. , 1988, The Journal of biological chemistry.

[18]  J. Kay.  Cysteine proteinases and their inhibitors : Edited by V. Turk Walter de Gruyter; Berlin, 1986 846 pages DM 390.00 , 1988 .

[19]  V. Turk,et al.  Isolation of kininogens using affinity chromatography , 1986 .

[20]  J. Shafer,et al.  Reactivity of small thiolate anions and cysteine-25 in papain toward methyl methanethiosulfonate. , 1986, Biochemistry.

[21]  A. Barrett,et al.  Isolation of six cysteine proteinase inhibitors from human urine. Their physicochemical and enzyme kinetic properties and concentrations in biological fluids. , 1986, The Journal of biological chemistry.

[22]  A. Barrett,et al.  Nomenclature and classification of the proteins homologous with the cysteine-proteinase inhibitor chicken cystatin. , 1986, The Biochemical journal.

[23]  A. Barrett,et al.  Human low-Mr kininogen contains three copies of a cystatin sequence that are divergent in structure and in inhibitory activity for cysteine proteinases. , 1986, The Biochemical journal.

[24]  R. Kageyama,et al.  Differential expression of the multiple forms of rat prekininogen mRNAs after acute inflammation. , 1985, The Journal of biological chemistry.

[25]  N. Kitamura,et al.  Cloning and sequence analysis of cDNAs for human high molecular weight and low molecular weight prekininogens. Primary structures of two human prekininogens. , 1985, The Journal of biological chemistry.

[26]  T. Miyata,et al.  Structural organization of the human kininogen gene and a model for its evolution. , 1985, The Journal of biological chemistry.

[27]  A. Barrett,et al.  The proteolytic activities of chymopapain, papain, and papaya proteinase III. , 1985, Biochimica et biophysica acta.

[28]  V. Turk,et al.  Human plasma kininogens are identical with alpha-cysteine proteinase inhibitors. Evidence from immunological, enzymological and sequence data. , 1985, FEBS letters.

[29]  K. Kurachi,et al.  Isolation of a human cDNA for alpha 2-thiol proteinase inhibitor and its identity with low molecular weight kininogen. , 1984, Biochemistry.

[30]  V. Turk,et al.  Protein inhibitors of cysteine proteinases. III. Amino-acid sequence of cystatin from chicken egg white. , 1983, Hoppe-Seyler's Zeitschrift fur physiologische Chemie.

[31]  H. Okamoto,et al.  Isolation and structure of T-kinin. , 1983, Biochemical and biophysical research communications.

[32]  A. Berger,et al.  The purification of papain by affinity chromatography. , 1970, European journal of biochemistry.

[33]  D. A. Yphantis.  EQUILIBRIUM ULTRACENTRIFUGATION OF DILUTE SOLUTIONS. , 1964, Biochemistry.